Gut Microbiome Plays an Important Role

Recent research underscores the essential role of the gut microbiome on cancer immunotherapy outcomes. Specific bacterial species, such as Akkermansia muciniphila and Faecalibacterium prausnitzii, have been found to be more prevalent in patients responding positively to immunotherapy. Conversely, bacteria like Enterocluster and Eggerthella lenta are more common in non-responders.

See the full article in PHARMACY TIMES: Emerging Frontiers: The Gut Microbiome Plays an Important Role in Enhancing Cancer Immunotherapy and Treatment Outcomes





------------------------------
anticancersynergies.com/